nodes	percent_of_prediction	percent_of_DWPC	metapath
Sulindac—osteoarthritis—Methylprednisolone—atopic dermatitis	0.275	0.5	CpDpCtD
Sulindac—osteoarthritis—Prednisone—atopic dermatitis	0.275	0.5	CpDpCtD
Sulindac—ALB—Tacrolimus—atopic dermatitis	0.0487	0.198	CbGbCtD
Sulindac—PTGS1—Diphenhydramine—atopic dermatitis	0.0477	0.194	CbGbCtD
Sulindac—PTGS2—Triamcinolone—atopic dermatitis	0.0392	0.159	CbGbCtD
Sulindac—PTGS2—Betamethasone—atopic dermatitis	0.0336	0.136	CbGbCtD
Sulindac—CYP1A2—Diphenhydramine—atopic dermatitis	0.0213	0.0865	CbGbCtD
Sulindac—ALB—Prednisone—atopic dermatitis	0.0198	0.0802	CbGbCtD
Sulindac—PTGS2—Dexamethasone—atopic dermatitis	0.0196	0.0794	CbGbCtD
Sulindac—CYP1A1—Dexamethasone—atopic dermatitis	0.0165	0.067	CbGbCtD
Sulindac—MAPK3—neck—atopic dermatitis	0.00053	0.192	CbGeAlD
Sulindac—PTGS2—Fluocinonide—Desonide—atopic dermatitis	0.000525	0.165	CbGdCrCtD
Sulindac—PTGS2—Fluocinonide—Fluocinolone Acetonide—atopic dermatitis	0.000409	0.128	CbGdCrCtD
Sulindac—MAPK3—skin of body—atopic dermatitis	0.000343	0.124	CbGeAlD
Sulindac—CYP1A1—skin epidermis—atopic dermatitis	0.000342	0.124	CbGeAlD
Sulindac—PTGS2—Fluocinonide—Mometasone—atopic dermatitis	0.000326	0.102	CbGdCrCtD
Sulindac—AKR1B1—head—atopic dermatitis	0.000309	0.112	CbGeAlD
Sulindac—PTGS2—skin epidermis—atopic dermatitis	0.000288	0.104	CbGeAlD
Sulindac—PTGS2—Fluticasone Propionate—Fluocinonide—atopic dermatitis	0.000254	0.0797	CbGdCrCtD
Sulindac—PTGS2—Fluticasone Propionate—Fluocinolone Acetonide—atopic dermatitis	0.000247	0.0774	CbGdCrCtD
Sulindac—PPARD—head—atopic dermatitis	0.000243	0.0881	CbGeAlD
Sulindac—MAPK3—head—atopic dermatitis	0.000224	0.0812	CbGeAlD
Sulindac—PTGS2—Fluticasone Propionate—Mometasone—atopic dermatitis	0.000197	0.0618	CbGdCrCtD
Sulindac—PTGS2—Fluocinonide—Methylprednisolone—atopic dermatitis	0.000195	0.0612	CbGdCrCtD
Sulindac—PTGS2—Fluocinonide—Dexamethasone—atopic dermatitis	0.000192	0.0602	CbGdCrCtD
Sulindac—PTGS2—Fluocinonide—Betamethasone—atopic dermatitis	0.000192	0.0602	CbGdCrCtD
Sulindac—PTGS2—Fluocinonide—Triamcinolone—atopic dermatitis	0.000187	0.0588	CbGdCrCtD
Sulindac—PTGS2—Fluticasone Propionate—Methylprednisolone—atopic dermatitis	0.000118	0.0369	CbGdCrCtD
Sulindac—PTGS2—Fluticasone Propionate—Dexamethasone—atopic dermatitis	0.000116	0.0363	CbGdCrCtD
Sulindac—PTGS2—Fluticasone Propionate—Betamethasone—atopic dermatitis	0.000116	0.0363	CbGdCrCtD
Sulindac—PTGS2—Fluticasone Propionate—Triamcinolone—atopic dermatitis	0.000113	0.0355	CbGdCrCtD
Sulindac—CYP1A1—skin of body—atopic dermatitis	0.000106	0.0385	CbGeAlD
Sulindac—Angioedema—Hydrocortisone—atopic dermatitis	0.000101	0.000877	CcSEcCtD
Sulindac—Malaise—Hydrocortisone—atopic dermatitis	0.0001	0.000865	CcSEcCtD
Sulindac—Loss of consciousness—Prednisolone—atopic dermatitis	9.98e-05	0.000863	CcSEcCtD
Sulindac—Vertigo—Hydrocortisone—atopic dermatitis	9.96e-05	0.000862	CcSEcCtD
Sulindac—Syncope—Hydrocortisone—atopic dermatitis	9.95e-05	0.00086	CcSEcCtD
Sulindac—Diarrhoea—Tacrolimus—atopic dermatitis	9.93e-05	0.000859	CcSEcCtD
Sulindac—Convulsion—Prednisolone—atopic dermatitis	9.84e-05	0.000851	CcSEcCtD
Sulindac—Hypertension—Prednisolone—atopic dermatitis	9.8e-05	0.000848	CcSEcCtD
Sulindac—Loss of consciousness—Hydrocortisone—atopic dermatitis	9.75e-05	0.000843	CcSEcCtD
Sulindac—Arrhythmia—Betamethasone—atopic dermatitis	9.72e-05	0.000841	CcSEcCtD
Sulindac—Arrhythmia—Dexamethasone—atopic dermatitis	9.72e-05	0.000841	CcSEcCtD
Sulindac—Ill-defined disorder—Triamcinolone—atopic dermatitis	9.69e-05	0.000838	CcSEcCtD
Sulindac—Ill-defined disorder—Methylprednisolone—atopic dermatitis	9.67e-05	0.000836	CcSEcCtD
Sulindac—Alopecia—Betamethasone—atopic dermatitis	9.62e-05	0.000832	CcSEcCtD
Sulindac—Alopecia—Dexamethasone—atopic dermatitis	9.62e-05	0.000832	CcSEcCtD
Sulindac—Convulsion—Hydrocortisone—atopic dermatitis	9.61e-05	0.000831	CcSEcCtD
Sulindac—Dizziness—Tacrolimus—atopic dermatitis	9.6e-05	0.00083	CcSEcCtD
Sulindac—Hypertension—Hydrocortisone—atopic dermatitis	9.58e-05	0.000828	CcSEcCtD
Sulindac—Discomfort—Prednisolone—atopic dermatitis	9.55e-05	0.000826	CcSEcCtD
Sulindac—Angioedema—Triamcinolone—atopic dermatitis	9.54e-05	0.000825	CcSEcCtD
Sulindac—Angioedema—Methylprednisolone—atopic dermatitis	9.52e-05	0.000824	CcSEcCtD
Sulindac—Myalgia—Hydrocortisone—atopic dermatitis	9.44e-05	0.000817	CcSEcCtD
Sulindac—Malaise—Triamcinolone—atopic dermatitis	9.42e-05	0.000815	CcSEcCtD
Sulindac—Malaise—Methylprednisolone—atopic dermatitis	9.4e-05	0.000813	CcSEcCtD
Sulindac—Vertigo—Triamcinolone—atopic dermatitis	9.38e-05	0.000812	CcSEcCtD
Sulindac—Syncope—Triamcinolone—atopic dermatitis	9.37e-05	0.00081	CcSEcCtD
Sulindac—Vertigo—Methylprednisolone—atopic dermatitis	9.36e-05	0.00081	CcSEcCtD
Sulindac—Syncope—Methylprednisolone—atopic dermatitis	9.34e-05	0.000808	CcSEcCtD
Sulindac—Discomfort—Hydrocortisone—atopic dermatitis	9.33e-05	0.000807	CcSEcCtD
Sulindac—PTGS1—skin of body—atopic dermatitis	9.32e-05	0.0338	CbGeAlD
Sulindac—Oedema—Prednisolone—atopic dermatitis	9.27e-05	0.000802	CcSEcCtD
Sulindac—Anaphylactic shock—Prednisolone—atopic dermatitis	9.27e-05	0.000802	CcSEcCtD
Sulindac—Vomiting—Tacrolimus—atopic dermatitis	9.23e-05	0.000798	CcSEcCtD
Sulindac—Loss of consciousness—Triamcinolone—atopic dermatitis	9.18e-05	0.000794	CcSEcCtD
Sulindac—Loss of consciousness—Methylprednisolone—atopic dermatitis	9.16e-05	0.000792	CcSEcCtD
Sulindac—Rash—Tacrolimus—atopic dermatitis	9.15e-05	0.000791	CcSEcCtD
Sulindac—Dermatitis—Tacrolimus—atopic dermatitis	9.14e-05	0.000791	CcSEcCtD
Sulindac—Shock—Prednisolone—atopic dermatitis	9.12e-05	0.000789	CcSEcCtD
Sulindac—Headache—Tacrolimus—atopic dermatitis	9.09e-05	0.000786	CcSEcCtD
Sulindac—Anaphylactic shock—Hydrocortisone—atopic dermatitis	9.05e-05	0.000783	CcSEcCtD
Sulindac—Oedema—Hydrocortisone—atopic dermatitis	9.05e-05	0.000783	CcSEcCtD
Sulindac—Convulsion—Triamcinolone—atopic dermatitis	9.05e-05	0.000783	CcSEcCtD
Sulindac—Tachycardia—Prednisolone—atopic dermatitis	9.05e-05	0.000782	CcSEcCtD
Sulindac—Convulsion—Methylprednisolone—atopic dermatitis	9.03e-05	0.000781	CcSEcCtD
Sulindac—Hypertension—Triamcinolone—atopic dermatitis	9.02e-05	0.00078	CcSEcCtD
Sulindac—Hypertension—Methylprednisolone—atopic dermatitis	9e-05	0.000778	CcSEcCtD
Sulindac—Hyperhidrosis—Prednisolone—atopic dermatitis	8.96e-05	0.000775	CcSEcCtD
Sulindac—PTGS2—skin of body—atopic dermatitis	8.91e-05	0.0323	CbGeAlD
Sulindac—Shock—Hydrocortisone—atopic dermatitis	8.91e-05	0.00077	CcSEcCtD
Sulindac—Myalgia—Triamcinolone—atopic dermatitis	8.89e-05	0.000769	CcSEcCtD
Sulindac—Myalgia—Methylprednisolone—atopic dermatitis	8.87e-05	0.000767	CcSEcCtD
Sulindac—Arthralgia—Methylprednisolone—atopic dermatitis	8.87e-05	0.000767	CcSEcCtD
Sulindac—Tachycardia—Hydrocortisone—atopic dermatitis	8.83e-05	0.000764	CcSEcCtD
Sulindac—Flushing—Prednisone—atopic dermatitis	8.8e-05	0.000761	CcSEcCtD
Sulindac—Ill-defined disorder—Betamethasone—atopic dermatitis	8.79e-05	0.000761	CcSEcCtD
Sulindac—Ill-defined disorder—Dexamethasone—atopic dermatitis	8.79e-05	0.000761	CcSEcCtD
Sulindac—Discomfort—Triamcinolone—atopic dermatitis	8.78e-05	0.00076	CcSEcCtD
Sulindac—Discomfort—Methylprednisolone—atopic dermatitis	8.76e-05	0.000758	CcSEcCtD
Sulindac—Hyperhidrosis—Hydrocortisone—atopic dermatitis	8.75e-05	0.000757	CcSEcCtD
Sulindac—Angioedema—Betamethasone—atopic dermatitis	8.66e-05	0.000749	CcSEcCtD
Sulindac—Angioedema—Dexamethasone—atopic dermatitis	8.66e-05	0.000749	CcSEcCtD
Sulindac—Anorexia—Hydrocortisone—atopic dermatitis	8.63e-05	0.000746	CcSEcCtD
Sulindac—Nausea—Tacrolimus—atopic dermatitis	8.62e-05	0.000746	CcSEcCtD
Sulindac—Malaise—Betamethasone—atopic dermatitis	8.55e-05	0.000739	CcSEcCtD
Sulindac—Malaise—Dexamethasone—atopic dermatitis	8.55e-05	0.000739	CcSEcCtD
Sulindac—Oedema—Triamcinolone—atopic dermatitis	8.52e-05	0.000737	CcSEcCtD
Sulindac—Anaphylactic shock—Triamcinolone—atopic dermatitis	8.52e-05	0.000737	CcSEcCtD
Sulindac—Vertigo—Dexamethasone—atopic dermatitis	8.51e-05	0.000736	CcSEcCtD
Sulindac—Vertigo—Betamethasone—atopic dermatitis	8.51e-05	0.000736	CcSEcCtD
Sulindac—Anaphylactic shock—Methylprednisolone—atopic dermatitis	8.5e-05	0.000736	CcSEcCtD
Sulindac—Syncope—Dexamethasone—atopic dermatitis	8.5e-05	0.000735	CcSEcCtD
Sulindac—Syncope—Betamethasone—atopic dermatitis	8.5e-05	0.000735	CcSEcCtD
Sulindac—Arrhythmia—Prednisone—atopic dermatitis	8.47e-05	0.000733	CcSEcCtD
Sulindac—Hypotension—Hydrocortisone—atopic dermatitis	8.46e-05	0.000732	CcSEcCtD
Sulindac—Shock—Triamcinolone—atopic dermatitis	8.39e-05	0.000725	CcSEcCtD
Sulindac—Insomnia—Prednisolone—atopic dermatitis	8.38e-05	0.000725	CcSEcCtD
Sulindac—Alopecia—Prednisone—atopic dermatitis	8.38e-05	0.000725	CcSEcCtD
Sulindac—Shock—Methylprednisolone—atopic dermatitis	8.37e-05	0.000724	CcSEcCtD
Sulindac—Loss of consciousness—Dexamethasone—atopic dermatitis	8.33e-05	0.00072	CcSEcCtD
Sulindac—Loss of consciousness—Betamethasone—atopic dermatitis	8.33e-05	0.00072	CcSEcCtD
Sulindac—Paraesthesia—Prednisolone—atopic dermatitis	8.32e-05	0.00072	CcSEcCtD
Sulindac—Tachycardia—Triamcinolone—atopic dermatitis	8.32e-05	0.00072	CcSEcCtD
Sulindac—Tachycardia—Methylprednisolone—atopic dermatitis	8.3e-05	0.000718	CcSEcCtD
Sulindac—Musculoskeletal discomfort—Hydrocortisone—atopic dermatitis	8.25e-05	0.000713	CcSEcCtD
Sulindac—Hyperhidrosis—Triamcinolone—atopic dermatitis	8.24e-05	0.000713	CcSEcCtD
Sulindac—Hyperhidrosis—Methylprednisolone—atopic dermatitis	8.22e-05	0.000711	CcSEcCtD
Sulindac—Convulsion—Dexamethasone—atopic dermatitis	8.21e-05	0.00071	CcSEcCtD
Sulindac—Convulsion—Betamethasone—atopic dermatitis	8.21e-05	0.00071	CcSEcCtD
Sulindac—Insomnia—Hydrocortisone—atopic dermatitis	8.19e-05	0.000708	CcSEcCtD
Sulindac—Hypertension—Betamethasone—atopic dermatitis	8.18e-05	0.000708	CcSEcCtD
Sulindac—Hypertension—Dexamethasone—atopic dermatitis	8.18e-05	0.000708	CcSEcCtD
Sulindac—Paraesthesia—Hydrocortisone—atopic dermatitis	8.13e-05	0.000703	CcSEcCtD
Sulindac—Myalgia—Dexamethasone—atopic dermatitis	8.07e-05	0.000698	CcSEcCtD
Sulindac—Myalgia—Betamethasone—atopic dermatitis	8.07e-05	0.000698	CcSEcCtD
Sulindac—Discomfort—Betamethasone—atopic dermatitis	7.97e-05	0.000689	CcSEcCtD
Sulindac—Discomfort—Dexamethasone—atopic dermatitis	7.97e-05	0.000689	CcSEcCtD
Sulindac—Dyspepsia—Hydrocortisone—atopic dermatitis	7.97e-05	0.000689	CcSEcCtD
Sulindac—Hypotension—Methylprednisolone—atopic dermatitis	7.95e-05	0.000687	CcSEcCtD
Sulindac—Decreased appetite—Hydrocortisone—atopic dermatitis	7.87e-05	0.000681	CcSEcCtD
Sulindac—Fatigue—Hydrocortisone—atopic dermatitis	7.8e-05	0.000675	CcSEcCtD
Sulindac—Vision blurred—Prednisone—atopic dermatitis	7.78e-05	0.000673	CcSEcCtD
Sulindac—Musculoskeletal discomfort—Triamcinolone—atopic dermatitis	7.77e-05	0.000672	CcSEcCtD
Sulindac—Musculoskeletal discomfort—Methylprednisolone—atopic dermatitis	7.75e-05	0.00067	CcSEcCtD
Sulindac—Oedema—Betamethasone—atopic dermatitis	7.73e-05	0.000669	CcSEcCtD
Sulindac—Anaphylactic shock—Dexamethasone—atopic dermatitis	7.73e-05	0.000669	CcSEcCtD
Sulindac—Oedema—Dexamethasone—atopic dermatitis	7.73e-05	0.000669	CcSEcCtD
Sulindac—Anaphylactic shock—Betamethasone—atopic dermatitis	7.73e-05	0.000669	CcSEcCtD
Sulindac—Insomnia—Triamcinolone—atopic dermatitis	7.71e-05	0.000667	CcSEcCtD
Sulindac—Insomnia—Methylprednisolone—atopic dermatitis	7.69e-05	0.000665	CcSEcCtD
Sulindac—Ill-defined disorder—Prednisone—atopic dermatitis	7.66e-05	0.000662	CcSEcCtD
Sulindac—Paraesthesia—Triamcinolone—atopic dermatitis	7.65e-05	0.000662	CcSEcCtD
Sulindac—Feeling abnormal—Prednisolone—atopic dermatitis	7.64e-05	0.000661	CcSEcCtD
Sulindac—Paraesthesia—Methylprednisolone—atopic dermatitis	7.64e-05	0.000661	CcSEcCtD
Sulindac—Anaemia—Prednisone—atopic dermatitis	7.63e-05	0.00066	CcSEcCtD
Sulindac—Shock—Dexamethasone—atopic dermatitis	7.61e-05	0.000658	CcSEcCtD
Sulindac—Shock—Betamethasone—atopic dermatitis	7.61e-05	0.000658	CcSEcCtD
Sulindac—Dyspnoea—Triamcinolone—atopic dermatitis	7.6e-05	0.000657	CcSEcCtD
Sulindac—Thrombocytopenia—Betamethasone—atopic dermatitis	7.57e-05	0.000655	CcSEcCtD
Sulindac—Thrombocytopenia—Dexamethasone—atopic dermatitis	7.57e-05	0.000655	CcSEcCtD
Sulindac—Tachycardia—Betamethasone—atopic dermatitis	7.55e-05	0.000653	CcSEcCtD
Sulindac—Tachycardia—Dexamethasone—atopic dermatitis	7.55e-05	0.000653	CcSEcCtD
Sulindac—Angioedema—Prednisone—atopic dermatitis	7.54e-05	0.000652	CcSEcCtD
Sulindac—Dyspepsia—Triamcinolone—atopic dermatitis	7.5e-05	0.000649	CcSEcCtD
Sulindac—Dyspepsia—Methylprednisolone—atopic dermatitis	7.49e-05	0.000648	CcSEcCtD
Sulindac—Hyperhidrosis—Dexamethasone—atopic dermatitis	7.48e-05	0.000647	CcSEcCtD
Sulindac—Hyperhidrosis—Betamethasone—atopic dermatitis	7.48e-05	0.000647	CcSEcCtD
Sulindac—Feeling abnormal—Hydrocortisone—atopic dermatitis	7.46e-05	0.000645	CcSEcCtD
Sulindac—Malaise—Prednisone—atopic dermatitis	7.44e-05	0.000644	CcSEcCtD
Sulindac—Vertigo—Prednisone—atopic dermatitis	7.41e-05	0.000641	CcSEcCtD
Sulindac—Gastrointestinal pain—Hydrocortisone—atopic dermatitis	7.4e-05	0.00064	CcSEcCtD
Sulindac—Syncope—Prednisone—atopic dermatitis	7.4e-05	0.00064	CcSEcCtD
Sulindac—Anorexia—Betamethasone—atopic dermatitis	7.37e-05	0.000638	CcSEcCtD
Sulindac—Anorexia—Dexamethasone—atopic dermatitis	7.37e-05	0.000638	CcSEcCtD
Sulindac—Urticaria—Prednisolone—atopic dermatitis	7.36e-05	0.000637	CcSEcCtD
Sulindac—Fatigue—Triamcinolone—atopic dermatitis	7.35e-05	0.000636	CcSEcCtD
Sulindac—Fatigue—Methylprednisolone—atopic dermatitis	7.33e-05	0.000634	CcSEcCtD
Sulindac—Loss of consciousness—Prednisone—atopic dermatitis	7.25e-05	0.000627	CcSEcCtD
Sulindac—Hypotension—Dexamethasone—atopic dermatitis	7.23e-05	0.000625	CcSEcCtD
Sulindac—Hypotension—Betamethasone—atopic dermatitis	7.23e-05	0.000625	CcSEcCtD
Sulindac—Urticaria—Hydrocortisone—atopic dermatitis	7.19e-05	0.000622	CcSEcCtD
Sulindac—Body temperature increased—Hydrocortisone—atopic dermatitis	7.16e-05	0.000619	CcSEcCtD
Sulindac—Convulsion—Prednisone—atopic dermatitis	7.15e-05	0.000618	CcSEcCtD
Sulindac—Hypertension—Prednisone—atopic dermatitis	7.12e-05	0.000616	CcSEcCtD
Sulindac—Musculoskeletal discomfort—Dexamethasone—atopic dermatitis	7.05e-05	0.000609	CcSEcCtD
Sulindac—Musculoskeletal discomfort—Betamethasone—atopic dermatitis	7.05e-05	0.000609	CcSEcCtD
Sulindac—Myalgia—Prednisone—atopic dermatitis	7.03e-05	0.000608	CcSEcCtD
Sulindac—Arthralgia—Prednisone—atopic dermatitis	7.03e-05	0.000608	CcSEcCtD
Sulindac—Feeling abnormal—Triamcinolone—atopic dermatitis	7.02e-05	0.000608	CcSEcCtD
Sulindac—Feeling abnormal—Methylprednisolone—atopic dermatitis	7.01e-05	0.000606	CcSEcCtD
Sulindac—Insomnia—Betamethasone—atopic dermatitis	6.99e-05	0.000605	CcSEcCtD
Sulindac—Insomnia—Dexamethasone—atopic dermatitis	6.99e-05	0.000605	CcSEcCtD
Sulindac—Gastrointestinal pain—Methylprednisolone—atopic dermatitis	6.95e-05	0.000602	CcSEcCtD
Sulindac—Paraesthesia—Betamethasone—atopic dermatitis	6.94e-05	0.000601	CcSEcCtD
Sulindac—Paraesthesia—Dexamethasone—atopic dermatitis	6.94e-05	0.000601	CcSEcCtD
Sulindac—Discomfort—Prednisone—atopic dermatitis	6.94e-05	0.0006	CcSEcCtD
Sulindac—CYP1A1—head—atopic dermatitis	6.92e-05	0.0251	CbGeAlD
Sulindac—Hypersensitivity—Prednisolone—atopic dermatitis	6.83e-05	0.000591	CcSEcCtD
Sulindac—Dyspepsia—Dexamethasone—atopic dermatitis	6.81e-05	0.000589	CcSEcCtD
Sulindac—Dyspepsia—Betamethasone—atopic dermatitis	6.81e-05	0.000589	CcSEcCtD
Sulindac—Urticaria—Triamcinolone—atopic dermatitis	6.77e-05	0.000586	CcSEcCtD
Sulindac—Urticaria—Methylprednisolone—atopic dermatitis	6.76e-05	0.000584	CcSEcCtD
Sulindac—Body temperature increased—Triamcinolone—atopic dermatitis	6.74e-05	0.000583	CcSEcCtD
Sulindac—Anaphylactic shock—Prednisone—atopic dermatitis	6.73e-05	0.000583	CcSEcCtD
Sulindac—Oedema—Prednisone—atopic dermatitis	6.73e-05	0.000583	CcSEcCtD
Sulindac—Decreased appetite—Dexamethasone—atopic dermatitis	6.72e-05	0.000582	CcSEcCtD
Sulindac—Decreased appetite—Betamethasone—atopic dermatitis	6.72e-05	0.000582	CcSEcCtD
Sulindac—Hypersensitivity—Hydrocortisone—atopic dermatitis	6.67e-05	0.000577	CcSEcCtD
Sulindac—Fatigue—Betamethasone—atopic dermatitis	6.67e-05	0.000577	CcSEcCtD
Sulindac—Fatigue—Dexamethasone—atopic dermatitis	6.67e-05	0.000577	CcSEcCtD
Sulindac—Shock—Prednisone—atopic dermatitis	6.63e-05	0.000573	CcSEcCtD
Sulindac—Tachycardia—Prednisone—atopic dermatitis	6.57e-05	0.000569	CcSEcCtD
Sulindac—Hyperhidrosis—Prednisone—atopic dermatitis	6.51e-05	0.000563	CcSEcCtD
Sulindac—Asthenia—Hydrocortisone—atopic dermatitis	6.49e-05	0.000562	CcSEcCtD
Sulindac—Anorexia—Prednisone—atopic dermatitis	6.42e-05	0.000555	CcSEcCtD
Sulindac—Pruritus—Hydrocortisone—atopic dermatitis	6.4e-05	0.000554	CcSEcCtD
Sulindac—Feeling abnormal—Dexamethasone—atopic dermatitis	6.37e-05	0.000551	CcSEcCtD
Sulindac—Feeling abnormal—Betamethasone—atopic dermatitis	6.37e-05	0.000551	CcSEcCtD
Sulindac—Gastrointestinal pain—Betamethasone—atopic dermatitis	6.32e-05	0.000547	CcSEcCtD
Sulindac—Gastrointestinal pain—Dexamethasone—atopic dermatitis	6.32e-05	0.000547	CcSEcCtD
Sulindac—Hypersensitivity—Triamcinolone—atopic dermatitis	6.28e-05	0.000543	CcSEcCtD
Sulindac—Hypersensitivity—Methylprednisolone—atopic dermatitis	6.27e-05	0.000542	CcSEcCtD
Sulindac—Diarrhoea—Hydrocortisone—atopic dermatitis	6.19e-05	0.000536	CcSEcCtD
Sulindac—Urticaria—Betamethasone—atopic dermatitis	6.14e-05	0.000531	CcSEcCtD
Sulindac—Urticaria—Dexamethasone—atopic dermatitis	6.14e-05	0.000531	CcSEcCtD
Sulindac—Musculoskeletal discomfort—Prednisone—atopic dermatitis	6.14e-05	0.000531	CcSEcCtD
Sulindac—Dizziness—Prednisolone—atopic dermatitis	6.13e-05	0.00053	CcSEcCtD
Sulindac—Asthenia—Triamcinolone—atopic dermatitis	6.12e-05	0.000529	CcSEcCtD
Sulindac—Body temperature increased—Dexamethasone—atopic dermatitis	6.11e-05	0.000529	CcSEcCtD
Sulindac—Body temperature increased—Betamethasone—atopic dermatitis	6.11e-05	0.000529	CcSEcCtD
Sulindac—Asthenia—Methylprednisolone—atopic dermatitis	6.1e-05	0.000528	CcSEcCtD
Sulindac—Insomnia—Prednisone—atopic dermatitis	6.09e-05	0.000527	CcSEcCtD
Sulindac—PTGS1—head—atopic dermatitis	6.08e-05	0.0221	CbGeAlD
Sulindac—PTGS1—Selenium Micronutrient Network—IL1B—atopic dermatitis	6.06e-05	0.000747	CbGpPWpGaD
Sulindac—Paraesthesia—Prednisone—atopic dermatitis	6.05e-05	0.000523	CcSEcCtD
Sulindac—Pruritus—Triamcinolone—atopic dermatitis	6.03e-05	0.000522	CcSEcCtD
Sulindac—ALB—Vitamin B12 Metabolism—IL1B—atopic dermatitis	6.02e-05	0.000743	CbGpPWpGaD
Sulindac—Pruritus—Methylprednisolone—atopic dermatitis	6.02e-05	0.00052	CcSEcCtD
Sulindac—Dizziness—Hydrocortisone—atopic dermatitis	5.99e-05	0.000518	CcSEcCtD
Sulindac—Dyspepsia—Prednisone—atopic dermatitis	5.93e-05	0.000513	CcSEcCtD
Sulindac—CYP1A1—PPARA activates gene expression—PPARA—atopic dermatitis	5.9e-05	0.000728	CbGpPWpGaD
Sulindac—PPARD—Metabolism of lipids and lipoproteins—PPARA—atopic dermatitis	5.88e-05	0.000726	CbGpPWpGaD
Sulindac—PTGS2—Aryl Hydrocarbon Receptor—TNF—atopic dermatitis	5.86e-05	0.000723	CbGpPWpGaD
Sulindac—Decreased appetite—Prednisone—atopic dermatitis	5.85e-05	0.000506	CcSEcCtD
Sulindac—MAPK3—Regulation of toll-like receptor signaling pathway—CXCL8—atopic dermatitis	5.85e-05	0.000721	CbGpPWpGaD
Sulindac—Rash—Prednisolone—atopic dermatitis	5.84e-05	0.000505	CcSEcCtD
Sulindac—Dermatitis—Prednisolone—atopic dermatitis	5.84e-05	0.000505	CcSEcCtD
Sulindac—MAPK3—Oxidative Stress Induced Senescence—MAPK8—atopic dermatitis	5.83e-05	0.000719	CbGpPWpGaD
Sulindac—MAPK3—NCAM signaling for neurite out-growth—IL6—atopic dermatitis	5.82e-05	0.000718	CbGpPWpGaD
Sulindac—Diarrhoea—Methylprednisolone—atopic dermatitis	5.82e-05	0.000503	CcSEcCtD
Sulindac—PTGS2—head—atopic dermatitis	5.81e-05	0.0211	CbGeAlD
Sulindac—Fatigue—Prednisone—atopic dermatitis	5.81e-05	0.000502	CcSEcCtD
Sulindac—Headache—Prednisolone—atopic dermatitis	5.81e-05	0.000502	CcSEcCtD
Sulindac—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—PPARA—atopic dermatitis	5.78e-05	0.000713	CbGpPWpGaD
Sulindac—Constipation—Prednisone—atopic dermatitis	5.76e-05	0.000498	CcSEcCtD
Sulindac—Vomiting—Hydrocortisone—atopic dermatitis	5.76e-05	0.000498	CcSEcCtD
Sulindac—MAPK3—Integrated Pancreatic Cancer Pathway—CASP8—atopic dermatitis	5.74e-05	0.000708	CbGpPWpGaD
Sulindac—MAPK3—Toll Like Receptor 4 (TLR4) Cascade—MAPK8—atopic dermatitis	5.71e-05	0.000704	CbGpPWpGaD
Sulindac—Rash—Hydrocortisone—atopic dermatitis	5.71e-05	0.000494	CcSEcCtD
Sulindac—Dermatitis—Hydrocortisone—atopic dermatitis	5.7e-05	0.000493	CcSEcCtD
Sulindac—Headache—Hydrocortisone—atopic dermatitis	5.67e-05	0.000491	CcSEcCtD
Sulindac—MAPK3—TNF alpha Signaling Pathway—TNF—atopic dermatitis	5.66e-05	0.000699	CbGpPWpGaD
Sulindac—Dizziness—Triamcinolone—atopic dermatitis	5.64e-05	0.000488	CcSEcCtD
Sulindac—Dizziness—Methylprednisolone—atopic dermatitis	5.62e-05	0.000486	CcSEcCtD
Sulindac—MAPK3—Regulation of toll-like receptor signaling pathway—IL1B—atopic dermatitis	5.61e-05	0.000692	CbGpPWpGaD
Sulindac—MAPK3—PDGFR-beta signaling pathway—MAPK8—atopic dermatitis	5.6e-05	0.000691	CbGpPWpGaD
Sulindac—MAPK3—Immune System—DEFB1—atopic dermatitis	5.59e-05	0.000689	CbGpPWpGaD
Sulindac—MAPK3—Signaling by NGF—NGF—atopic dermatitis	5.58e-05	0.000689	CbGpPWpGaD
Sulindac—ALB—SLC-mediated transmembrane transport—SLC11A1—atopic dermatitis	5.58e-05	0.000689	CbGpPWpGaD
Sulindac—Feeling abnormal—Prednisone—atopic dermatitis	5.55e-05	0.00048	CcSEcCtD
Sulindac—Asthenia—Dexamethasone—atopic dermatitis	5.55e-05	0.00048	CcSEcCtD
Sulindac—Asthenia—Betamethasone—atopic dermatitis	5.55e-05	0.00048	CcSEcCtD
Sulindac—Gastrointestinal pain—Prednisone—atopic dermatitis	5.51e-05	0.000476	CcSEcCtD
Sulindac—Nausea—Prednisolone—atopic dermatitis	5.51e-05	0.000476	CcSEcCtD
Sulindac—PTGS2—Metabolism of lipids and lipoproteins—GLB1—atopic dermatitis	5.5e-05	0.000679	CbGpPWpGaD
Sulindac—ALB—Folate Metabolism—IFNG—atopic dermatitis	5.49e-05	0.000677	CbGpPWpGaD
Sulindac—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—atopic dermatitis	5.49e-05	0.000677	CbGpPWpGaD
Sulindac—MAPK3—Signaling by GPCR—CCL17—atopic dermatitis	5.48e-05	0.000677	CbGpPWpGaD
Sulindac—Pruritus—Betamethasone—atopic dermatitis	5.47e-05	0.000473	CcSEcCtD
Sulindac—Pruritus—Dexamethasone—atopic dermatitis	5.47e-05	0.000473	CcSEcCtD
Sulindac—SLC22A6—Transmembrane transport of small molecules—SLC11A1—atopic dermatitis	5.46e-05	0.000673	CbGpPWpGaD
Sulindac—Vomiting—Triamcinolone—atopic dermatitis	5.42e-05	0.000469	CcSEcCtD
Sulindac—Vomiting—Methylprednisolone—atopic dermatitis	5.41e-05	0.000468	CcSEcCtD
Sulindac—PTGS2—C-MYB transcription factor network—CD4—atopic dermatitis	5.41e-05	0.000667	CbGpPWpGaD
Sulindac—PTGS2—Selenium Micronutrient Network—IFNG—atopic dermatitis	5.39e-05	0.000665	CbGpPWpGaD
Sulindac—MAPK3—TRAF6 Mediated Induction of proinflammatory cytokines—IL6—atopic dermatitis	5.38e-05	0.000664	CbGpPWpGaD
Sulindac—MAPK3—Interferon Signaling—IFNG—atopic dermatitis	5.38e-05	0.000664	CbGpPWpGaD
Sulindac—Nausea—Hydrocortisone—atopic dermatitis	5.38e-05	0.000465	CcSEcCtD
Sulindac—Rash—Triamcinolone—atopic dermatitis	5.37e-05	0.000465	CcSEcCtD
Sulindac—Dermatitis—Triamcinolone—atopic dermatitis	5.37e-05	0.000464	CcSEcCtD
Sulindac—Rash—Methylprednisolone—atopic dermatitis	5.36e-05	0.000464	CcSEcCtD
Sulindac—Dermatitis—Methylprednisolone—atopic dermatitis	5.36e-05	0.000463	CcSEcCtD
Sulindac—Urticaria—Prednisone—atopic dermatitis	5.35e-05	0.000463	CcSEcCtD
Sulindac—Headache—Triamcinolone—atopic dermatitis	5.34e-05	0.000462	CcSEcCtD
Sulindac—Headache—Methylprednisolone—atopic dermatitis	5.33e-05	0.000461	CcSEcCtD
Sulindac—Body temperature increased—Prednisone—atopic dermatitis	5.32e-05	0.000461	CcSEcCtD
Sulindac—Diarrhoea—Betamethasone—atopic dermatitis	5.29e-05	0.000458	CcSEcCtD
Sulindac—Diarrhoea—Dexamethasone—atopic dermatitis	5.29e-05	0.000458	CcSEcCtD
Sulindac—PTGDR2—Signaling Pathways—CXCL10—atopic dermatitis	5.24e-05	0.000647	CbGpPWpGaD
Sulindac—MAPK3—Toll-like Receptor Signaling Pathway—TNF—atopic dermatitis	5.21e-05	0.000643	CbGpPWpGaD
Sulindac—CYP1A1—Aryl Hydrocarbon Receptor—TNF—atopic dermatitis	5.2e-05	0.000642	CbGpPWpGaD
Sulindac—CYP1A1—Aryl Hydrocarbon Receptor Pathway—TNF—atopic dermatitis	5.2e-05	0.000642	CbGpPWpGaD
Sulindac—MAPK3—Hemostasis—IL5—atopic dermatitis	5.2e-05	0.000642	CbGpPWpGaD
Sulindac—PTGS2—Integrated Pancreatic Cancer Pathway—BDNF—atopic dermatitis	5.17e-05	0.000637	CbGpPWpGaD
Sulindac—MAPK3—Regulation of toll-like receptor signaling pathway—MAPK8—atopic dermatitis	5.14e-05	0.000635	CbGpPWpGaD
Sulindac—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IFNG—atopic dermatitis	5.13e-05	0.000632	CbGpPWpGaD
Sulindac—Dizziness—Betamethasone—atopic dermatitis	5.11e-05	0.000442	CcSEcCtD
Sulindac—Dizziness—Dexamethasone—atopic dermatitis	5.11e-05	0.000442	CcSEcCtD
Sulindac—MAPK3—Toll-Like Receptors Cascades—MAPK8—atopic dermatitis	5.09e-05	0.000627	CbGpPWpGaD
Sulindac—Nausea—Triamcinolone—atopic dermatitis	5.06e-05	0.000438	CcSEcCtD
Sulindac—Nausea—Methylprednisolone—atopic dermatitis	5.05e-05	0.000437	CcSEcCtD
Sulindac—MAPK3—Glucocorticoid receptor regulatory network—IL6—atopic dermatitis	5.01e-05	0.000618	CbGpPWpGaD
Sulindac—MAPK3—BDNF signaling pathway—MAPK8—atopic dermatitis	5e-05	0.000617	CbGpPWpGaD
Sulindac—Hypersensitivity—Prednisone—atopic dermatitis	4.96e-05	0.000429	CcSEcCtD
Sulindac—MAPK3—Innate Immune System—CASP1—atopic dermatitis	4.94e-05	0.00061	CbGpPWpGaD
Sulindac—MAPK3—Disease—GLB1—atopic dermatitis	4.92e-05	0.000607	CbGpPWpGaD
Sulindac—Vomiting—Dexamethasone—atopic dermatitis	4.92e-05	0.000425	CcSEcCtD
Sulindac—Vomiting—Betamethasone—atopic dermatitis	4.92e-05	0.000425	CcSEcCtD
Sulindac—ALB—Folate Metabolism—IL1B—atopic dermatitis	4.9e-05	0.000604	CbGpPWpGaD
Sulindac—CYP1A1—Metabolism of lipids and lipoproteins—GLB1—atopic dermatitis	4.88e-05	0.000603	CbGpPWpGaD
Sulindac—ALB—Folate Metabolism—IL2—atopic dermatitis	4.88e-05	0.000602	CbGpPWpGaD
Sulindac—Rash—Dexamethasone—atopic dermatitis	4.88e-05	0.000422	CcSEcCtD
Sulindac—Rash—Betamethasone—atopic dermatitis	4.88e-05	0.000422	CcSEcCtD
Sulindac—Dermatitis—Dexamethasone—atopic dermatitis	4.87e-05	0.000421	CcSEcCtD
Sulindac—Dermatitis—Betamethasone—atopic dermatitis	4.87e-05	0.000421	CcSEcCtD
Sulindac—MAPK3—IRS-mediated signalling—IL6—atopic dermatitis	4.87e-05	0.000601	CbGpPWpGaD
Sulindac—MAPK3—MyD88 cascade initiated on plasma membrane—IL6—atopic dermatitis	4.87e-05	0.000601	CbGpPWpGaD
Sulindac—ALB—Platelet activation, signaling and aggregation—IL5—atopic dermatitis	4.86e-05	0.000599	CbGpPWpGaD
Sulindac—Headache—Betamethasone—atopic dermatitis	4.84e-05	0.000419	CcSEcCtD
Sulindac—Headache—Dexamethasone—atopic dermatitis	4.84e-05	0.000419	CcSEcCtD
Sulindac—Asthenia—Prednisone—atopic dermatitis	4.83e-05	0.000418	CcSEcCtD
Sulindac—MAPK3—TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation—IL6—atopic dermatitis	4.82e-05	0.000595	CbGpPWpGaD
Sulindac—MAPK3—MAPK Signaling Pathway—IL1B—atopic dermatitis	4.82e-05	0.000595	CbGpPWpGaD
Sulindac—PTGS2—Selenium Micronutrient Network—IL1B—atopic dermatitis	4.81e-05	0.000593	CbGpPWpGaD
Sulindac—Pruritus—Prednisone—atopic dermatitis	4.76e-05	0.000412	CcSEcCtD
Sulindac—MAPK3—MyD88 dependent cascade initiated on endosome—IL6—atopic dermatitis	4.74e-05	0.000584	CbGpPWpGaD
Sulindac—MAPK3—IRS-related events—IL6—atopic dermatitis	4.74e-05	0.000584	CbGpPWpGaD
Sulindac—MAPK3—IRS-related events triggered by IGF1R—IL6—atopic dermatitis	4.69e-05	0.000579	CbGpPWpGaD
Sulindac—MAPK3—TCR Signaling Pathway—IL6—atopic dermatitis	4.65e-05	0.000574	CbGpPWpGaD
Sulindac—MAPK3—Spinal Cord Injury—TNF—atopic dermatitis	4.64e-05	0.000573	CbGpPWpGaD
Sulindac—MAPK3—Cellular Senescence—CXCL8—atopic dermatitis	4.63e-05	0.000571	CbGpPWpGaD
Sulindac—Diarrhoea—Prednisone—atopic dermatitis	4.61e-05	0.000399	CcSEcCtD
Sulindac—MAPK3—Signaling by NGF—NFKBIA—atopic dermatitis	4.6e-05	0.000568	CbGpPWpGaD
Sulindac—MAPK3—Insulin Signaling—MAPK8—atopic dermatitis	4.6e-05	0.000567	CbGpPWpGaD
Sulindac—Nausea—Betamethasone—atopic dermatitis	4.59e-05	0.000397	CcSEcCtD
Sulindac—Nausea—Dexamethasone—atopic dermatitis	4.59e-05	0.000397	CcSEcCtD
Sulindac—PTGDR2—GPCR downstream signaling—CXCL8—atopic dermatitis	4.58e-05	0.000565	CbGpPWpGaD
Sulindac—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL1B—atopic dermatitis	4.57e-05	0.000564	CbGpPWpGaD
Sulindac—MAPK3—IGF1R signaling cascade—IL6—atopic dermatitis	4.57e-05	0.000564	CbGpPWpGaD
Sulindac—MAPK3—TNF alpha Signaling Pathway—IL6—atopic dermatitis	4.57e-05	0.000564	CbGpPWpGaD
Sulindac—MAPK3—Toll Like Receptor 9 (TLR9) Cascade—IL6—atopic dermatitis	4.57e-05	0.000564	CbGpPWpGaD
Sulindac—MAPK3—Insulin receptor signalling cascade—IL6—atopic dermatitis	4.57e-05	0.000564	CbGpPWpGaD
Sulindac—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—atopic dermatitis	4.56e-05	0.000562	CbGpPWpGaD
Sulindac—PTGDR2—Signaling Pathways—CCL5—atopic dermatitis	4.51e-05	0.000557	CbGpPWpGaD
Sulindac—MAPK3—MyD88:Mal cascade initiated on plasma membrane—IL6—atopic dermatitis	4.49e-05	0.000554	CbGpPWpGaD
Sulindac—MAPK3—Innate Immune System—TLR2—atopic dermatitis	4.47e-05	0.000551	CbGpPWpGaD
Sulindac—MAPK3—Immune System—KIF3A—atopic dermatitis	4.47e-05	0.000551	CbGpPWpGaD
Sulindac—Dizziness—Prednisone—atopic dermatitis	4.45e-05	0.000385	CcSEcCtD
Sulindac—ALB—Metabolism of lipids and lipoproteins—GLB1—atopic dermatitis	4.45e-05	0.000549	CbGpPWpGaD
Sulindac—MAPK3—Signaling by GPCR—CCL11—atopic dermatitis	4.42e-05	0.000545	CbGpPWpGaD
Sulindac—MAPK3—MAPK Signaling Pathway—MAPK8—atopic dermatitis	4.42e-05	0.000545	CbGpPWpGaD
Sulindac—PTGS1—Selenium Micronutrient Network—TNF—atopic dermatitis	4.4e-05	0.000542	CbGpPWpGaD
Sulindac—PTGDR2—GPCR downstream signaling—IL2—atopic dermatitis	4.38e-05	0.00054	CbGpPWpGaD
Sulindac—ALB—Vitamin B12 Metabolism—TNF—atopic dermatitis	4.37e-05	0.000539	CbGpPWpGaD
Sulindac—ALB—Selenium Micronutrient Network—IFNG—atopic dermatitis	4.36e-05	0.000538	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—FCER2—atopic dermatitis	4.36e-05	0.000538	CbGpPWpGaD
Sulindac—MAPK3—MyD88-independent cascade—IL6—atopic dermatitis	4.31e-05	0.000532	CbGpPWpGaD
Sulindac—Vomiting—Prednisone—atopic dermatitis	4.28e-05	0.00037	CcSEcCtD
Sulindac—PTGS2—Spinal Cord Injury—IFNG—atopic dermatitis	4.26e-05	0.000526	CbGpPWpGaD
Sulindac—Rash—Prednisone—atopic dermatitis	4.25e-05	0.000367	CcSEcCtD
Sulindac—Dermatitis—Prednisone—atopic dermatitis	4.24e-05	0.000367	CcSEcCtD
Sulindac—MAPK3—Fc epsilon receptor (FCERI) signaling—MAPK8—atopic dermatitis	4.24e-05	0.000523	CbGpPWpGaD
Sulindac—Headache—Prednisone—atopic dermatitis	4.22e-05	0.000365	CcSEcCtD
Sulindac—MAPK3—Toll-like Receptor Signaling Pathway—IL6—atopic dermatitis	4.21e-05	0.000519	CbGpPWpGaD
Sulindac—PTGDR2—Signaling Pathways—NGF—atopic dermatitis	4.18e-05	0.000515	CbGpPWpGaD
Sulindac—PTGDR2—Signaling by GPCR—CXCL8—atopic dermatitis	4.16e-05	0.000513	CbGpPWpGaD
Sulindac—MAPK3—Senescence-Associated Secretory Phenotype (SASP)—IL6—atopic dermatitis	4.11e-05	0.000507	CbGpPWpGaD
Sulindac—ALB—Hemostasis—KIF3A—atopic dermatitis	4.1e-05	0.000506	CbGpPWpGaD
Sulindac—MAPK3—Cellular Senescence—MAPK8—atopic dermatitis	4.08e-05	0.000503	CbGpPWpGaD
Sulindac—MAPK3—Regulation of toll-like receptor signaling pathway—TNF—atopic dermatitis	4.07e-05	0.000502	CbGpPWpGaD
Sulindac—PTGDR2—Signaling Pathways—CCR5—atopic dermatitis	4.07e-05	0.000501	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—CCL22—atopic dermatitis	4.05e-05	0.0005	CbGpPWpGaD
Sulindac—MAPK3—VEGFA-VEGFR2 Pathway—IL6—atopic dermatitis	4.05e-05	0.0005	CbGpPWpGaD
Sulindac—MAPK3—Signaling by Interleukins—IL6—atopic dermatitis	4.02e-05	0.000496	CbGpPWpGaD
Sulindac—Nausea—Prednisone—atopic dermatitis	4e-05	0.000346	CcSEcCtD
Sulindac—MAPK3—Integrated Pancreatic Cancer Pathway—MAPK8—atopic dermatitis	3.99e-05	0.000492	CbGpPWpGaD
Sulindac—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—PPARA—atopic dermatitis	3.98e-05	0.000491	CbGpPWpGaD
Sulindac—PTGDR2—Signaling by GPCR—IL2—atopic dermatitis	3.98e-05	0.00049	CbGpPWpGaD
Sulindac—PTGS2—Spinal Cord Injury—CXCL8—atopic dermatitis	3.97e-05	0.000489	CbGpPWpGaD
Sulindac—ALB—Selenium Micronutrient Network—IL1B—atopic dermatitis	3.89e-05	0.00048	CbGpPWpGaD
Sulindac—MAPK3—Activated TLR4 signalling—IL6—atopic dermatitis	3.88e-05	0.000478	CbGpPWpGaD
Sulindac—MAPK3—Platelet activation, signaling and aggregation—IL2—atopic dermatitis	3.86e-05	0.000476	CbGpPWpGaD
Sulindac—MAPK3—Signaling by VEGF—IL6—atopic dermatitis	3.82e-05	0.000472	CbGpPWpGaD
Sulindac—PTGS2—Spinal Cord Injury—IL1B—atopic dermatitis	3.8e-05	0.000469	CbGpPWpGaD
Sulindac—MAPK3—Immune System—STAT6—atopic dermatitis	3.8e-05	0.000469	CbGpPWpGaD
Sulindac—MAPK3—Signaling by Insulin receptor—IL6—atopic dermatitis	3.8e-05	0.000468	CbGpPWpGaD
Sulindac—PTGS2—Spinal Cord Injury—IL2—atopic dermatitis	3.79e-05	0.000467	CbGpPWpGaD
Sulindac—PTGS2—Integrated Pancreatic Cancer Pathway—NFKBIA—atopic dermatitis	3.78e-05	0.000467	CbGpPWpGaD
Sulindac—MAPK3—Spinal Cord Injury—IL6—atopic dermatitis	3.75e-05	0.000462	CbGpPWpGaD
Sulindac—MAPK3—Immune System—CARD11—atopic dermatitis	3.69e-05	0.000456	CbGpPWpGaD
Sulindac—MAPK3—Toll Like Receptor 4 (TLR4) Cascade—IL6—atopic dermatitis	3.65e-05	0.00045	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—CCL27—atopic dermatitis	3.61e-05	0.000446	CbGpPWpGaD
Sulindac—MAPK3—Signaling by GPCR—CCR3—atopic dermatitis	3.6e-05	0.000445	CbGpPWpGaD
Sulindac—MAPK3—Cytokine Signaling in Immune system—IFNG—atopic dermatitis	3.59e-05	0.000443	CbGpPWpGaD
Sulindac—ALB—Folate Metabolism—TNF—atopic dermatitis	3.55e-05	0.000438	CbGpPWpGaD
Sulindac—PTGS1—Selenium Micronutrient Network—IL6—atopic dermatitis	3.55e-05	0.000438	CbGpPWpGaD
Sulindac—ALB—Vitamin B12 Metabolism—IL6—atopic dermatitis	3.53e-05	0.000435	CbGpPWpGaD
Sulindac—MAPK3—Cellular responses to stress—CXCL8—atopic dermatitis	3.5e-05	0.000432	CbGpPWpGaD
Sulindac—MAPK3—MAPK Signaling Pathway—TNF—atopic dermatitis	3.5e-05	0.000432	CbGpPWpGaD
Sulindac—PTGS2—Selenium Micronutrient Network—TNF—atopic dermatitis	3.49e-05	0.000431	CbGpPWpGaD
Sulindac—PTGDR2—Signaling Pathways—NFKBIA—atopic dermatitis	3.45e-05	0.000425	CbGpPWpGaD
Sulindac—PTGS2—Integrated Pancreatic Cancer Pathway—CASP8—atopic dermatitis	3.41e-05	0.000421	CbGpPWpGaD
Sulindac—PPARD—Gene Expression—PPARA—atopic dermatitis	3.37e-05	0.000416	CbGpPWpGaD
Sulindac—MAPK3—Developmental Biology—PPARA—atopic dermatitis	3.36e-05	0.000415	CbGpPWpGaD
Sulindac—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—atopic dermatitis	3.32e-05	0.000409	CbGpPWpGaD
Sulindac—CYP1A2—Aryl Hydrocarbon Receptor—TNF—atopic dermatitis	3.32e-05	0.000409	CbGpPWpGaD
Sulindac—ALB—Hemostasis—SELE—atopic dermatitis	3.3e-05	0.000408	CbGpPWpGaD
Sulindac—MAPK3—Disease—SLC11A1—atopic dermatitis	3.3e-05	0.000407	CbGpPWpGaD
Sulindac—MAPK3—Regulation of toll-like receptor signaling pathway—IL6—atopic dermatitis	3.29e-05	0.000405	CbGpPWpGaD
Sulindac—MAPK3—Signaling by SCF-KIT—IL6—atopic dermatitis	3.25e-05	0.000401	CbGpPWpGaD
Sulindac—MAPK3—Toll-Like Receptors Cascades—IL6—atopic dermatitis	3.25e-05	0.000401	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—CCL17—atopic dermatitis	3.24e-05	0.0004	CbGpPWpGaD
Sulindac—MAPK3—Signaling by GPCR—TAC1—atopic dermatitis	3.21e-05	0.000396	CbGpPWpGaD
Sulindac—MAPK3—Signaling by GPCR—NPS—atopic dermatitis	3.21e-05	0.000396	CbGpPWpGaD
Sulindac—MAPK3—Cytokine Signaling in Immune system—IL1B—atopic dermatitis	3.2e-05	0.000395	CbGpPWpGaD
Sulindac—MAPK3—Cytokine Signaling in Immune system—IL2—atopic dermatitis	3.19e-05	0.000394	CbGpPWpGaD
Sulindac—MAPK3—Integrated Pancreatic Cancer Pathway—TNF—atopic dermatitis	3.16e-05	0.000389	CbGpPWpGaD
Sulindac—MAPK3—Signaling by GPCR—CXCR3—atopic dermatitis	3.15e-05	0.000389	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism of lipids and lipoproteins—GLB1—atopic dermatitis	3.11e-05	0.000384	CbGpPWpGaD
Sulindac—MAPK3—Downstream signaling of activated FGFR—IL6—atopic dermatitis	3.11e-05	0.000383	CbGpPWpGaD
Sulindac—PTGS1—Metabolism—GLB1—atopic dermatitis	3.09e-05	0.000381	CbGpPWpGaD
Sulindac—MAPK3—Cellular responses to stress—MAPK8—atopic dermatitis	3.08e-05	0.00038	CbGpPWpGaD
Sulindac—MAPK3—Signaling by ERBB4—IL6—atopic dermatitis	3.06e-05	0.000377	CbGpPWpGaD
Sulindac—MAPK3—Signaling by GPCR—IL5—atopic dermatitis	2.99e-05	0.000368	CbGpPWpGaD
Sulindac—PTGS1—Metabolism—ADSL—atopic dermatitis	2.96e-05	0.000365	CbGpPWpGaD
Sulindac—PTGS2—Disease—GLB1—atopic dermatitis	2.93e-05	0.000361	CbGpPWpGaD
Sulindac—MAPK3—Downstream signal transduction—IL6—atopic dermatitis	2.92e-05	0.00036	CbGpPWpGaD
Sulindac—MAPK3—Signaling by FGFR—IL6—atopic dermatitis	2.91e-05	0.000359	CbGpPWpGaD
Sulindac—MAPK3—Signaling by ERBB2—IL6—atopic dermatitis	2.89e-05	0.000357	CbGpPWpGaD
Sulindac—MAPK3—Signaling by NGF—MAPK8—atopic dermatitis	2.89e-05	0.000356	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—KIF3A—atopic dermatitis	2.89e-05	0.000356	CbGpPWpGaD
Sulindac—MAPK3—Immune System—CASP1—atopic dermatitis	2.88e-05	0.000355	CbGpPWpGaD
Sulindac—MAPK3—DAP12 signaling—IL6—atopic dermatitis	2.88e-05	0.000355	CbGpPWpGaD
Sulindac—ALB—Folate Metabolism—IL6—atopic dermatitis	2.87e-05	0.000354	CbGpPWpGaD
Sulindac—ALB—Transmembrane transport of small molecules—SLC11A1—atopic dermatitis	2.84e-05	0.00035	CbGpPWpGaD
Sulindac—ALB—Selenium Micronutrient Network—TNF—atopic dermatitis	2.82e-05	0.000348	CbGpPWpGaD
Sulindac—PTGS2—Selenium Micronutrient Network—IL6—atopic dermatitis	2.82e-05	0.000347	CbGpPWpGaD
Sulindac—PTGS2—Spinal Cord Injury—TNF—atopic dermatitis	2.76e-05	0.00034	CbGpPWpGaD
Sulindac—MAPK3—Immune System—IL5—atopic dermatitis	2.73e-05	0.000337	CbGpPWpGaD
Sulindac—MAPK3—DAP12 interactions—IL6—atopic dermatitis	2.71e-05	0.000334	CbGpPWpGaD
Sulindac—MAPK3—Fc epsilon receptor (FCERI) signaling—IL6—atopic dermatitis	2.71e-05	0.000334	CbGpPWpGaD
Sulindac—MAPK3—Signaling by FGFR in disease—IL6—atopic dermatitis	2.71e-05	0.000334	CbGpPWpGaD
Sulindac—MAPK3—Signaling by EGFR—IL6—atopic dermatitis	2.68e-05	0.000331	CbGpPWpGaD
Sulindac—MAPK3—Signaling by EGFR in Cancer—IL6—atopic dermatitis	2.66e-05	0.000328	CbGpPWpGaD
Sulindac—MAPK3—Signaling by PDGF—IL6—atopic dermatitis	2.65e-05	0.000327	CbGpPWpGaD
Sulindac—SLC22A6—Transmembrane transport of small molecules—PPARA—atopic dermatitis	2.64e-05	0.000326	CbGpPWpGaD
Sulindac—MAPK3—Innate Immune System—NFKBIA—atopic dermatitis	2.63e-05	0.000324	CbGpPWpGaD
Sulindac—PPARD—Metabolism—PPARA—atopic dermatitis	2.62e-05	0.000323	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—CCL11—atopic dermatitis	2.61e-05	0.000322	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—CMA1—atopic dermatitis	2.61e-05	0.000322	CbGpPWpGaD
Sulindac—MAPK3—Immune System—TLR2—atopic dermatitis	2.6e-05	0.000321	CbGpPWpGaD
Sulindac—MAPK3—Cellular Senescence—IL6—atopic dermatitis	2.6e-05	0.000321	CbGpPWpGaD
Sulindac—MAPK3—Signaling by GPCR—CXCL10—atopic dermatitis	2.55e-05	0.000314	CbGpPWpGaD
Sulindac—ALB—Hemostasis—IL5—atopic dermatitis	2.5e-05	0.000309	CbGpPWpGaD
Sulindac—PTGDR2—Signaling Pathways—CXCL8—atopic dermatitis	2.46e-05	0.000303	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—STAT6—atopic dermatitis	2.46e-05	0.000303	CbGpPWpGaD
Sulindac—PTGS2—Metabolism—GLB1—atopic dermatitis	2.45e-05	0.000302	CbGpPWpGaD
Sulindac—MAPK3—Immune System—CD79A—atopic dermatitis	2.45e-05	0.000302	CbGpPWpGaD
Sulindac—MAPK3—NGF signalling via TRKA from the plasma membrane—IL6—atopic dermatitis	2.4e-05	0.000296	CbGpPWpGaD
Sulindac—PTGS2—Integrated Pancreatic Cancer Pathway—MAPK8—atopic dermatitis	2.37e-05	0.000293	CbGpPWpGaD
Sulindac—MAPK3—Innate Immune System—CASP8—atopic dermatitis	2.37e-05	0.000292	CbGpPWpGaD
Sulindac—PTGS2—Metabolism—ADSL—atopic dermatitis	2.35e-05	0.00029	CbGpPWpGaD
Sulindac—PTGDR2—Signaling Pathways—IL2—atopic dermatitis	2.35e-05	0.00029	CbGpPWpGaD
Sulindac—PTGDR2—Signaling by GPCR—IL6—atopic dermatitis	2.34e-05	0.000288	CbGpPWpGaD
Sulindac—MAPK3—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—atopic dermatitis	2.32e-05	0.000286	CbGpPWpGaD
Sulindac—ALB—Selenium Micronutrient Network—IL6—atopic dermatitis	2.28e-05	0.000281	CbGpPWpGaD
Sulindac—PTGS1—Metabolism of lipids and lipoproteins—PPARA—atopic dermatitis	2.25e-05	0.000278	CbGpPWpGaD
Sulindac—PTGS2—Spinal Cord Injury—IL6—atopic dermatitis	2.23e-05	0.000275	CbGpPWpGaD
Sulindac—MAPK3—Signaling by GPCR—CCL5—atopic dermatitis	2.19e-05	0.00027	CbGpPWpGaD
Sulindac—CYP1A1—Metabolism—GLB1—atopic dermatitis	2.18e-05	0.000268	CbGpPWpGaD
Sulindac—PTGDR2—Signaling Pathways—MAPK8—atopic dermatitis	2.16e-05	0.000267	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—CCR3—atopic dermatitis	2.13e-05	0.000263	CbGpPWpGaD
Sulindac—CYP1A1—Metabolism—ADSL—atopic dermatitis	2.09e-05	0.000257	CbGpPWpGaD
Sulindac—MAPK3—Immune System—IL18—atopic dermatitis	2e-05	0.000247	CbGpPWpGaD
Sulindac—MAPK3—Hemostasis—IL2—atopic dermatitis	1.99e-05	0.000245	CbGpPWpGaD
Sulindac—ALB—Metabolism—GLB1—atopic dermatitis	1.98e-05	0.000245	CbGpPWpGaD
Sulindac—MAPK3—Signaling by GPCR—CCR5—atopic dermatitis	1.97e-05	0.000244	CbGpPWpGaD
Sulindac—MAPK3—Immune System—CD8A—atopic dermatitis	1.97e-05	0.000243	CbGpPWpGaD
Sulindac—MAPK3—Cellular responses to stress—IL6—atopic dermatitis	1.97e-05	0.000243	CbGpPWpGaD
Sulindac—PTGS2—Disease—SLC11A1—atopic dermatitis	1.96e-05	0.000242	CbGpPWpGaD
Sulindac—MAPK3—Innate Immune System—CD4—atopic dermatitis	1.95e-05	0.00024	CbGpPWpGaD
Sulindac—ALB—Metabolism—ADSL—atopic dermatitis	1.9e-05	0.000235	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—TAC1—atopic dermatitis	1.9e-05	0.000234	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—NPS—atopic dermatitis	1.9e-05	0.000234	CbGpPWpGaD
Sulindac—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—atopic dermatitis	1.88e-05	0.000232	CbGpPWpGaD
Sulindac—MAPK3—Cytokine Signaling in Immune system—IL6—atopic dermatitis	1.88e-05	0.000231	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—CXCR3—atopic dermatitis	1.86e-05	0.00023	CbGpPWpGaD
Sulindac—ALB—Platelet activation, signaling and aggregation—IL2—atopic dermatitis	1.86e-05	0.000229	CbGpPWpGaD
Sulindac—MAPK3—Signaling by NGF—IL6—atopic dermatitis	1.84e-05	0.000228	CbGpPWpGaD
Sulindac—PTGS2—Metabolism of lipids and lipoproteins—PPARA—atopic dermatitis	1.79e-05	0.00022	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—IL5—atopic dermatitis	1.76e-05	0.000218	CbGpPWpGaD
Sulindac—MAPK3—Gene Expression—PPARA—atopic dermatitis	1.72e-05	0.000212	CbGpPWpGaD
Sulindac—MAPK3—Axon guidance—IL6—atopic dermatitis	1.67e-05	0.000206	CbGpPWpGaD
Sulindac—MAPK3—Disease—CCR5—atopic dermatitis	1.67e-05	0.000205	CbGpPWpGaD
Sulindac—MAPK3—Innate Immune System—MAPK8—atopic dermatitis	1.65e-05	0.000203	CbGpPWpGaD
Sulindac—CYP1A1—Metabolism of lipids and lipoproteins—PPARA—atopic dermatitis	1.59e-05	0.000196	CbGpPWpGaD
Sulindac—MAPK3—Immune System—NFKBIA—atopic dermatitis	1.53e-05	0.000189	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—CXCL10—atopic dermatitis	1.5e-05	0.000186	CbGpPWpGaD
Sulindac—MAPK3—Developmental Biology—TNF—atopic dermatitis	1.48e-05	0.000182	CbGpPWpGaD
Sulindac—ALB—Metabolism of lipids and lipoproteins—PPARA—atopic dermatitis	1.45e-05	0.000178	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—GLB1—atopic dermatitis	1.39e-05	0.000171	CbGpPWpGaD
Sulindac—PTGDR2—Signaling Pathways—IL6—atopic dermatitis	1.38e-05	0.00017	CbGpPWpGaD
Sulindac—MAPK3—Immune System—CASP8—atopic dermatitis	1.38e-05	0.00017	CbGpPWpGaD
Sulindac—ALB—Transmembrane transport of small molecules—PPARA—atopic dermatitis	1.37e-05	0.000169	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—ADSL—atopic dermatitis	1.33e-05	0.000164	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—CCL5—atopic dermatitis	1.29e-05	0.00016	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—NGF—atopic dermatitis	1.2e-05	0.000148	CbGpPWpGaD
Sulindac—MAPK3—Signaling by GPCR—CXCL8—atopic dermatitis	1.19e-05	0.000147	CbGpPWpGaD
Sulindac—MAPK3—Developmental Biology—IL6—atopic dermatitis	1.19e-05	0.000147	CbGpPWpGaD
Sulindac—MAPK3—Immune System—IFNG—atopic dermatitis	1.17e-05	0.000145	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—CCR5—atopic dermatitis	1.17e-05	0.000144	CbGpPWpGaD
Sulindac—MAPK3—Signaling by GPCR—IL2—atopic dermatitis	1.14e-05	0.000141	CbGpPWpGaD
Sulindac—MAPK3—Immune System—CD4—atopic dermatitis	1.13e-05	0.00014	CbGpPWpGaD
Sulindac—MAPK3—Innate Immune System—IL6—atopic dermatitis	1.05e-05	0.00013	CbGpPWpGaD
Sulindac—MAPK3—Immune System—IL1B—atopic dermatitis	1.05e-05	0.000129	CbGpPWpGaD
Sulindac—MAPK3—Disease—CD4—atopic dermatitis	1.05e-05	0.000129	CbGpPWpGaD
Sulindac—MAPK3—Immune System—IL2—atopic dermatitis	1.04e-05	0.000129	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism of lipids and lipoproteins—PPARA—atopic dermatitis	1.01e-05	0.000125	CbGpPWpGaD
Sulindac—PTGS1—Metabolism—PPARA—atopic dermatitis	1e-05	0.000124	CbGpPWpGaD
Sulindac—PTGS2—Disease—CCR5—atopic dermatitis	9.91e-06	0.000122	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—NFKBIA—atopic dermatitis	9.89e-06	0.000122	CbGpPWpGaD
Sulindac—MAPK3—Immune System—MAPK8—atopic dermatitis	9.6e-06	0.000118	CbGpPWpGaD
Sulindac—ALB—Hemostasis—IL2—atopic dermatitis	9.57e-06	0.000118	CbGpPWpGaD
Sulindac—PTGS2—Metabolism—PPARA—atopic dermatitis	7.95e-06	9.81e-05	CbGpPWpGaD
Sulindac—CYP1A1—Metabolism—PPARA—atopic dermatitis	7.06e-06	8.71e-05	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—CXCL8—atopic dermatitis	7.05e-06	8.7e-05	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—IL2—atopic dermatitis	6.74e-06	8.31e-05	CbGpPWpGaD
Sulindac—MAPK3—Signaling by GPCR—IL6—atopic dermatitis	6.71e-06	8.27e-05	CbGpPWpGaD
Sulindac—ALB—Metabolism—PPARA—atopic dermatitis	6.44e-06	7.94e-05	CbGpPWpGaD
Sulindac—PTGS2—Disease—CD4—atopic dermatitis	6.22e-06	7.67e-05	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—MAPK8—atopic dermatitis	6.2e-06	7.65e-05	CbGpPWpGaD
Sulindac—MAPK3—Immune System—IL6—atopic dermatitis	6.13e-06	7.56e-05	CbGpPWpGaD
Sulindac—MAPK3—Disease—IL6—atopic dermatitis	5.66e-06	6.98e-05	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—PPARA—atopic dermatitis	4.5e-06	5.55e-05	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—IL6—atopic dermatitis	3.96e-06	4.89e-05	CbGpPWpGaD
Sulindac—PTGS2—Disease—IL6—atopic dermatitis	3.36e-06	4.15e-05	CbGpPWpGaD
